Or Refractory Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2020-01-22
  Clinical Trial Update: Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia [Phase 1]

  Phase 1 trial evaluating vincristine, doxorubicin, dexamethasone, and ixazomib in relapsed/refractory ALL, relapsed/refractory lymphoblastic…

• CLINICAL_TRIALS trial_result · 2017-01-20
  Clinical Trial Update: A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL [Phase 1]

  Phase I clinical trial evaluating the safety and initial efficacy of C-CAR011, a CD19-targeted CAR-T therapy, in adults with relapsed or ref…